Exelixis
EXEL
#1791
Rank
A$16.76 B
Marketcap
A$62.29
Share price
1.22%
Change (1 day)
9.95%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company